Gerard Griffioen,Bart De Taeye,Katrien Princen,Koen De Witte,Emilie Blanche,Hasane Ratni,Matthias Nettekoven,Mark Rogers-Evans
申请号：
US15122959
公开号：
US10562869B2
申请日:
2015.03.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a compound of formula (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein R1, R2, R3, L1, L2, L3, L4, L5 and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.
